VIRIDIAN BIOSCIENCES
Viridian is a biopharma incubator, founded to strengthen the link between scientific discovery and product commercialization. Viridian leverages validated scientific findings and a deep appreciation of evolving unmet needs to identify opportunities with strong underlying science, de-risking translational data, and a high unmet need. Upon validation of these “program hypotheses”, Viridian establishes new companies, led initially by the Viridian team, to pursue the discovery and development of first-in-class or best-in-class new molecules.
VIRIDIAN BIOSCIENCES
Industry:
Medical Product Search Therapeutics
Status:
Closed
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS AWS Global Accelerator
Similar Organizations
Barrier Therapeutics
Barrier Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization.
CorneaCare
Personalized dry eye treatment delivered and monitored.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-12-10 | Quellis Biosciences | Viridian Biosciences investment in Series A - Quellis Biosciences | 17 M USD |